These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18770029)

  • 1. Therapeutic strategy for ischemic stroke.
    Yamashita T; Deguchi K; Sehara Y; Lukic-Panin V; Zhang H; Kamiya T; Abe K
    Neurochem Res; 2009 Apr; 34(4):707-10. PubMed ID: 18770029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene and stem cell therapy in ischemic stroke.
    Yamashita T; Deguchi K; Nagotani S; Kamiya T; Abe K
    Cell Transplant; 2009; 18(9):999-1002. PubMed ID: 19523331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection and neurosupplementation in ischaemic brain.
    Yamashita T; Deguchi K; Sawamoto K; Okano H; Kamiya T; Abe K
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1310-2. PubMed ID: 17073809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular protection and restorative therapy in ischemic stroke.
    Yamashita T; Deguchi K; Nagotani S; Abe K
    Cell Transplant; 2011; 20(1):95-7. PubMed ID: 20887680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress in Therapeutic Strategies for Ischemic Stroke.
    Yamashita T; Abe K
    Cell Transplant; 2016; 25(5):893-8. PubMed ID: 26786838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
    Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M
    J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF and neuroprotection: a therapeutic perspective in cerebral ischaemia.
    Lu CZ; Xiao BG
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1327-33. PubMed ID: 17073813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to improve post-stroke behavioral recovery in aged subjects.
    Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
    Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats.
    Sun BL; He MQ; Han XY; Sun JY; Yang MF; Yuan H; Fan CD; Zhang S; Mao LL; Li DW; Zhang ZY; Zheng CB; Yang XY; Li YV; Stetler RA; Chen J; Zhang F
    Mol Neurobiol; 2016 Jan; 53(1):320-330. PubMed ID: 25432887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
    Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M
    Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
    Lukic-Panin V; Kamiya T; Zhang H; Hayashi T; Tsuchiya A; Sehara Y; Deguchi K; Yamashita T; Abe K
    Brain Res; 2007 Oct; 1176():143-50. PubMed ID: 17904110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection in acute ischemic stroke--current status.
    Auriel E; Bornstein NM
    J Cell Mol Med; 2010 Sep; 14(9):2200-2. PubMed ID: 20716132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats.
    Omote Y; Deguchi K; Kono S; Liu W; Kurata T; Hishikawa N; Yamashita T; Ikeda Y; Abe K
    J Neurosci Res; 2014 Oct; 92(10):1330-7. PubMed ID: 24839960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection of G-CSF in cerebral ischemia.
    Lu CZ; Xiao BG
    Front Biosci; 2007 May; 12():2869-75. PubMed ID: 17485265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study.
    Watanabe M; Hirano T; Okamoto S; Shiraishi S; Tomiguchi S; Uchino M
    Hypertens Res; 2010 Jan; 33(1):43-8. PubMed ID: 19876061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor regulates JNK pathway to alleviate damage after cerebral ischemia reperfusion.
    Li YG; Liu XL; Zheng CB
    Chin Med J (Engl); 2013 Nov; 126(21):4088-92. PubMed ID: 24229679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-colony stimulating factor protects against endoplasmic reticulum stress in an experimental model of stroke.
    Menzie-Suderam JM; Mohammad-Gharibani P; Modi J; Ma Z; Tao R; Prentice H; Wu JY
    Brain Res; 2018 Mar; 1682():1-13. PubMed ID: 29277709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain repair by hematopoietic growth factors in a rat model of stroke.
    Zhao LR; Singhal S; Duan WM; Mehta J; Kessler JA
    Stroke; 2007 Sep; 38(9):2584-91. PubMed ID: 17656664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating acute ischemic stroke.
    Fisher M; Bastan B
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.